Medicare Enrolled
Dr. Scott Ulmer, M.D.
Hematology & Oncology · San Antonio, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ulmer from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ulmer? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ulmer
Dr. Scott Ulmer is a hematology & oncology in San Antonio, TX, with 19 years in practice. Based on federal Medicare data, Dr. Ulmer performed 96,527 Medicare services across 4,895 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ulmer received a total of $29,750 from 49 pharmaceutical and/or device companies across 178 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ulmer is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 8% volume in TX$ $29,750 industry payments
Medicare Practice Summary
Medicare Utilization ↗96,527
Medicare services
Top 8% in TX for hematology & oncology
4,895
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~5,080 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) | 58,500 | $1 | $3 |
| Pembrolizumab injection (Keytruda) | 19,000 | $43 | $165 |
| Dexamethasone injection (steroid) | 2,550 | $0 | $0 |
| Denosumab injection (Prolia/Xgeva) | 1,980 | $19 | $72 |
| Complete blood count (CBC) with differential | 1,548 | $8 | $23 |
| Comprehensive metabolic blood panel | 1,425 | $10 | $32 |
| Blood draw (venipuncture) | 1,334 | $8 | $14 |
| Office visit, established patient (20-29 min) | 946 | $66 | $263 |
| Lactate dehydrogenase (enzyme) level | 802 | $6 | $18 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 652 | $22 | $86 |
| Ferritin level test (iron stores) | 508 | $13 | $41 |
| Iron level test | 502 | $6 | $19 |
| Iron binding capacity test | 502 | $9 | $26 |
| Injection of additional new drug or substance into vein | 471 | $11 | $58 |
| Administration of chemotherapy into vein, 1 hour or less | 461 | $98 | $376 |
| Office visit, established patient (30-39 min) | 459 | $91 | $373 |
| Magnesium level test | 398 | $7 | $20 |
| Anti-nausea injection (ondansetron/Zofran) | 340 | $0 | $2 |
| Immunoglobulin level test | 317 | $9 | $28 |
| Office visit, established patient, complex (40-54 min) | 307 | $132 | $523 |
| Complete blood count (CBC), automated | 285 | $6 | $19 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 276 | $49 | $185 |
| Injection, diphenhydramine hcl, up to 50 mg | 260 | $1 | $3 |
| Carcinoembryonic antigen (cea) protein level | 222 | $19 | $57 |
| Injection, zoledronic acid, 1 mg | 222 | $7 | $70 |
| Unclassified drugs | 201 | $1 | $1 |
| Drug injection, under skin or into muscle | 161 | $10 | $47 |
| Administration of additional new drug or substance into vein, 1 hour or less | 157 | $49 | $205 |
| Basic metabolic blood panel | 128 | $8 | $25 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 123 | $336 | $1,305 |
| Administration of chemotherapy into vein, each additional hour | 120 | $21 | $90 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 117 | $4 | $17 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 113 | $16 | $60 |
| Infusion into a vein for hydration, each additional hour | 112 | $10 | $42 |
| Infusion, normal saline solution , 1000 cc | 109 | $2 | $19 |
| Prothrombin time test (blood clotting) | 81 | $4 | $13 |
| Hospital follow-up visit, moderate complexity | 70 | $62 | $232 |
| Vitamin B-12 level test | 69 | $15 | $45 |
| Hospital follow-up visit, high complexity | 68 | $92 | $349 |
| Phosphate level test | 64 | $5 | $14 |
| PSA test (prostate cancer screening) | 64 | $18 | $55 |
| Drawing of blood for a medical problem | 52 | $66 | $279 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 | 50 | $20 | $62 |
| Infusion into a vein for hydration, 31-60 minutes | 48 | $25 | $137 |
| New patient office visit, complex (60-74 min) | 46 | $168 | $651 |
| Hospital follow-up visit, low complexity | 45 | $38 | $145 |
| Coagulation assessment blood test, plasma or whole blood | 32 | $6 | $18 |
| Hepatitis c antibody measurement | 28 | $14 | $43 |
| Hepatitis b core antibody (igm) measurement | 27 | $12 | $35 |
| Hepatitis b surface antibody measurement | 26 | $11 | $32 |
| Detection test by immunoassay technique for hepatitis b surface antigen | 26 | $10 | $31 |
| New patient office visit (45-59 min) | 23 | $115 | $529 |
| Detection test by immunoassay technique for hiv-1 antigen and hiv-1 and hiv-2 antibodies | 20 | $24 | $72 |
| Free thyroxine (T4) test | 19 | $9 | $27 |
| Thyroid stimulating hormone (TSH) test | 17 | $16 | $50 |
| Telephone medical discussion with physician, 11-20 minutes | 17 | $61 | $263 |
| New patient office visit (30-44 min) | 14 | $81 | $356 |
| Initial hospital admission, high complexity | 13 | $136 | $589 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
62.0% high complexity
26.7% medium
11.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$29,750
Total received (2018-2024)
Avg $4,250/year across 7 years
Top 16% in TX for hematology & oncology
49
Companies
178
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$23,592 (79.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,421 (14.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,737 (5.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$5,813
2023$1,224
2022$9,168
2021$3,876
2020$1,432
2019$569
2018$7,667
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$6,051
Gilead Sciences, Inc.
$3,932
AstraZeneca Pharmaceuticals LP
$3,183
Karyopharm Therapeutics Inc.
$2,675
Kite Pharma, Inc.
$2,425
Genmab U.S., Inc.
$1,907
GENZYME CORPORATION
$1,626
Janssen Biotech, Inc.
$1,405
Athenex Pharmaceutical Division, LLC
$1,250
Varian Medical Systems, Inc.
$750
Adaptive Biotechnologies Corporation
$709
Novartis Pharmaceuticals Corporation
$590
Siemens Medical Solutions USA, Inc.
$375
Genentech USA, Inc.
$340
GlaxoSmithKline, LLC.
$319
E.R. Squibb & Sons, L.L.C.
$279
Astellas Pharma US Inc
$237
Tempus AI, Inc
$236
Amgen Inc.
$204
Takeda Pharmaceuticals U.S.A., Inc.
$160
PharmaEssentia USA Corporation
$125
Daiichi Sankyo Inc.
$116
CTI BioPharma Corp.
$73
Alexion Pharmaceuticals, Inc.
$70
Merck Sharp & Dohme LLC
$70
Lilly USA, LLC
$66
AVEO Pharmaceuticals, Inc.
$54
Apellis Pharmaceuticals, Inc.
$53
Regeneron Healthcare Solutions, Inc.
$42
Heron Therapeutics, Inc.
$41
Janssen Pharmaceuticals, Inc
$34
Celgene Corporation
$29
Medtronic USA, Inc.
$28
TAIHO ONCOLOGY, INC.
$27
BeiGene USA, Inc.
$24
Sumitomo Pharma America, Inc.
$23
ADC Therapeutics America, Inc.
$23
Fennec Pharmaceuticals, Inc.
$22
ABBVIE INC.
$21
PUMA BIOTECHNOLOGY, INC.
$20
Mirati Therapeutics, Inc.
$19
BAXTER HEALTHCARE
$17
Blueprint Medicines Corporation
$15
Bayer HealthCare Pharmaceuticals Inc.
$15
SERVIER PHARMACEUTICALS LLC
$15
Amneal Pharmaceuticals LLC
$15
Exelixis Inc.
$13
Agios Pharmaceuticals, Inc.
$13
Foundation Medicine, Inc.
$13
Top 3 companies account for 44.3% of total payments
Associated products mentioned in payments ›
ARIA Radiation Therapy Management Software · AVASTIN · AYVAKIT · BESREMI · BLENREP · BOSULIF · BRUKINSA · CABLIVI · CABOMETYX · CALQUENCE · CINVANTI · DARZALEX · ELIQUIS · ENHERTU · EPKINLY · Empaveli · Enhertu · Epkinly · FOTIVDA · FOUNDATIONONE · Fabhalta · GAZYVA · Gazyva · IBRANCE · ICLUSIG · JADENU · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUTATHERA · Lunsumio · MEKINIST · MYLOTARG · NERLYNX · Nubeqa · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · Oral Paclitaxel · PADCEV · PROMACTA · PYRUKYND · Padcev · Pedmark · REBLOZYL · RYDAPT · Renal - Prismaflex TPE sets · SANDOSTATIN · SARCLISA · SCEMBLIX · SOLIRIS · SUTENT · SYNCHROMED · TASIGNA · TECENTRIQ · TECVAYLI · Tecartus · Tibsovo · ULTOMIRIS · VERZENIO · Vonjo · Vyloy · XALKORI · XARELTO · XPOVIO · Yescarta · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (79%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Equivalent to $31 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
57
Per 100K population
2.8
County median income
$70,571
Nearest hospital
SOUTH TEXAS SPINE AND SURGICAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Ulmer is a mixed practice specialist, with above-average Medicare volume (top 8% in TX), and high industry engagement (consulting-driven, top 16%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Ulmer experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Ulmer performed 58,500 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ulmer receive payments from pharmaceutical companies?
Yes. Dr. Ulmer received a total of $29,750 from 49 companies across 178 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ulmer's costs compare to other hematology & oncologys in San Antonio?
Dr. Ulmer's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ulmer) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in San Antonio
Browse hematology & oncologys in San Antonio ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in TX
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in TX
Which TX hematology & oncologys receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc..
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology